B2M and chronic kidney disease: As B2M plasma levels are commonly elevated in CKD patients [18] per se and elevated plasma levels account for two out of ten points in the weighted CLL-IPI risk score, we next analyzed the frequency and distribution of elevated B2M plasma levels in our cohort.